Formulation and Optimization of Cilnidipine Nanoparticle-loaded Mucoadhesive Buccal Tablets using Quality by Design Approach for Enhanced Systemic Bioavailability
Cilnidipine, a calcium channel blocker used to treat hypertension, has poor oral bioavailability owing to extensive first-pass intestinal and hepatic metabolism. Buccal delivery offers an alternative route that bypasses hepatic first-pass metabolism and provides controlled systemic absorption. This study aimed to f...